Synaptive Medical Inc.’s brain simulator training kit, which simulates the features of a living brain to allow users to practice procedures such as stitching a blood vessel, has received an honorable mention in the health category of Fast Company’s 2017 Innovation by Design Awards.
CAAP company SensOR Medical's ForceFilm technology, a thin add-on for minimally invasive surgical (MIS) instruments that provides surgeons with a digital sense of touch to help improve surgical safety, was selected as the Canadian James Dyson Award winner. SensOR will receive $3,400 toward ForceFilm’s development.
SensOR will now enter the International competition, where it will go up against other national winners for the ultimate $50,000 prize.
MaRS Innovation and Evotec AG today announced the launch of “LAB150”. This transformational Toronto-based partnership will give Canada access to the world-class infrastructure and drug discovery expertise of Evotec, and pair it with cutting-edge drug discovery projects emerging from the 15 Member institutions of MaRS Innovation.
Lab150 is a joint effort by MaRS Innovation and Evotec AG selection and acceleration of early-stage drug discovery projects originating from leading academic institutions and teaching hospitals in Toronto (Canada)
Seed funding for novel, high-risk, high-reward translational research to accelerate the development of safe and effective treatments for neurodegenerative diseases of aging. Funding up to $200,000 over up to 18 months
Letter of Intent Deadline: December 4, 2017 at 2pm EST
Program Information Session: October 10, 2017 at 1pm EDT (Register here)
Therapure Biopharma Inc. today announced that a joint venture between 3SBio Inc., a leading global biotechnology company, and CPE Funds has entered into an agreement to acquire Therapure’s contract development and manufacturing (CDMO) business and certain rights to plasma products and technology for the Chinese market for US$290 million, subject to certain adjustments.